Conrado, D.J., et al.; “The Coalition Against Major Diseases: Towards U.S. FDA qualification of hippocampal volume as a biomarker for enrichment in clinical trials for pre-dementia stages of Alzheimer’s disease.” Alzheimer’s Association International Conference, London, UK, July 16-20, 2017, Alzheimer’s & Dementia 12(7): Suppl., 1259.
